List of Tables
Table 1. Global Biotechnology and Pharmaceutical Gases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Biotechnology and Pharmaceutical Gases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Biotechnology and Pharmaceutical Gases Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biotechnology and Pharmaceutical Gases Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Biotechnology and Pharmaceutical Gases Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
Table 7. Global Biotechnology and Pharmaceutical Gases Sales by Region (2020-2025) & (Kilotons)
Table 8. Global Biotechnology and Pharmaceutical Gases Sales by Region (2026-2031) & (Kilotons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Biotechnology and Pharmaceutical Gases Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
Table 11. Global Biotechnology and Pharmaceutical Gases Production by Region (2020-2025) & (Kilotons)
Table 12. Global Biotechnology and Pharmaceutical Gases Production by Region (2026-2031) & (Kilotons)
Table 13. Global Biotechnology and Pharmaceutical Gases Sales by Manufacturers (2020-2025) & (Kilotons)
Table 14. Global Biotechnology and Pharmaceutical Gases Sales Share by Manufacturers (2020-2025)
Table 15. Global Biotechnology and Pharmaceutical Gases Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Biotechnology and Pharmaceutical Gases Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Biotechnology and Pharmaceutical Gases by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnology and Pharmaceutical Gases as of 2024)
Table 19. Global Biotechnology and Pharmaceutical Gases Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Biotechnology and Pharmaceutical Gases Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Biotechnology and Pharmaceutical Gases Manufacturing Base and Headquarters
Table 22. Global Biotechnology and Pharmaceutical Gases Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Biotechnology and Pharmaceutical Gases Sales by Type (2020-2025) & (Kilotons)
Table 26. Global Biotechnology and Pharmaceutical Gases Sales by Type (2026-2031) & (Kilotons)
Table 27. Global Biotechnology and Pharmaceutical Gases Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Biotechnology and Pharmaceutical Gases Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Biotechnology and Pharmaceutical Gases ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Biotechnology and Pharmaceutical Gases Sales by Application (2020-2025) & (Kilotons)
Table 32. Global Biotechnology and Pharmaceutical Gases Sales by Application (2026-2031) & (Kilotons)
Table 33. Biotechnology and Pharmaceutical Gases High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Biotechnology and Pharmaceutical Gases Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Biotechnology and Pharmaceutical Gases Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Biotechnology and Pharmaceutical Gases ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Biotechnology and Pharmaceutical Gases Growth Accelerators and Market Barriers
Table 40. North America Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Biotechnology and Pharmaceutical Gases Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Biotechnology and Pharmaceutical Gases Growth Accelerators and Market Barriers
Table 43. Europe Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Biotechnology and Pharmaceutical Gases Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Biotechnology and Pharmaceutical Gases Growth Accelerators and Market Barriers
Table 48. Southeast Asia Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Biotechnology and Pharmaceutical Gases Investment Opportunities and Key Challenges
Table 50. Central and South America Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Biotechnology and Pharmaceutical Gases Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Air Liquide Corporation Information
Table 54. Air Liquide Description and Major Businesses
Table 55. Air Liquide Product Models, Descriptions and Specifications
Table 56. Air Liquide Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Air Liquide Sales Value Proportion by Product in 2024
Table 58. Air Liquide Sales Value Proportion by Application in 2024
Table 59. Air Liquide Sales Value Proportion by Geographic Area in 2024
Table 60. Air Liquide Biotechnology and Pharmaceutical Gases SWOT Analysis
Table 61. Air Liquide Recent Developments
Table 62. Linde Corporation Information
Table 63. Linde Description and Major Businesses
Table 64. Linde Product Models, Descriptions and Specifications
Table 65. Linde Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Linde Sales Value Proportion by Product in 2024
Table 67. Linde Sales Value Proportion by Application in 2024
Table 68. Linde Sales Value Proportion by Geographic Area in 2024
Table 69. Linde Biotechnology and Pharmaceutical Gases SWOT Analysis
Table 70. Linde Recent Developments
Table 71. Air Products Corporation Information
Table 72. Air Products Description and Major Businesses
Table 73. Air Products Product Models, Descriptions and Specifications
Table 74. Air Products Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Air Products Sales Value Proportion by Product in 2024
Table 76. Air Products Sales Value Proportion by Application in 2024
Table 77. Air Products Sales Value Proportion by Geographic Area in 2024
Table 78. Air Products Biotechnology and Pharmaceutical Gases SWOT Analysis
Table 79. Air Products Recent Developments
Table 80. Taiyo Nippon Sanso Corporation Information
Table 81. Taiyo Nippon Sanso Description and Major Businesses
Table 82. Taiyo Nippon Sanso Product Models, Descriptions and Specifications
Table 83. Taiyo Nippon Sanso Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Taiyo Nippon Sanso Sales Value Proportion by Product in 2024
Table 85. Taiyo Nippon Sanso Sales Value Proportion by Application in 2024
Table 86. Taiyo Nippon Sanso Sales Value Proportion by Geographic Area in 2024
Table 87. Taiyo Nippon Sanso Biotechnology and Pharmaceutical Gases SWOT Analysis
Table 88. Taiyo Nippon Sanso Recent Developments
Table 89. Matheson Corporation Information
Table 90. Matheson Description and Major Businesses
Table 91. Matheson Product Models, Descriptions and Specifications
Table 92. Matheson Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Matheson Sales Value Proportion by Product in 2024
Table 94. Matheson Sales Value Proportion by Application in 2024
Table 95. Matheson Sales Value Proportion by Geographic Area in 2024
Table 96. Matheson Biotechnology and Pharmaceutical Gases SWOT Analysis
Table 97. Matheson Recent Developments
Table 98. Messer Group Corporation Information
Table 99. Messer Group Description and Major Businesses
Table 100. Messer Group Product Models, Descriptions and Specifications
Table 101. Messer Group Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Messer Group Recent Developments
Table 103. SOL Group Corporation Information
Table 104. SOL Group Description and Major Businesses
Table 105. SOL Group Product Models, Descriptions and Specifications
Table 106. SOL Group Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. SOL Group Recent Developments
Table 108. Coregas Corporation Information
Table 109. Coregas Description and Major Businesses
Table 110. Coregas Product Models, Descriptions and Specifications
Table 111. Coregas Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Coregas Recent Developments
Table 113. INOX Air Products Corporation Information
Table 114. INOX Air Products Description and Major Businesses
Table 115. INOX Air Products Product Models, Descriptions and Specifications
Table 116. INOX Air Products Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. INOX Air Products Recent Developments
Table 118. HangYang Corporation Information
Table 119. HangYang Description and Major Businesses
Table 120. HangYang Product Models, Descriptions and Specifications
Table 121. HangYang Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. HangYang Recent Developments
Table 123. Shenzhen Gaofa Gas Corporation Information
Table 124. Shenzhen Gaofa Gas Description and Major Businesses
Table 125. Shenzhen Gaofa Gas Product Models, Descriptions and Specifications
Table 126. Shenzhen Gaofa Gas Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 127. Shenzhen Gaofa Gas Recent Developments
Table 128. Key Raw Materials Distribution
Table 129. Raw Materials Key Suppliers
Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 131. Milestones in Production Technology Evolution
Table 132. Distributors List
Table 133. Market Trends and Market Evolution
Table 134. Market Drivers and Opportunities
Table 135. Market Challenges, Risks, and Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Biotechnology and Pharmaceutical Gases Product Picture
Figure 2. Global Biotechnology and Pharmaceutical Gases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Carbon Dioxide Product Picture
Figure 4. Nitrogen Product Picture
Figure 5. Oxygen Product Picture
Figure 6. Others Product Picture
Figure 7. Global Biotechnology and Pharmaceutical Gases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Laboratory
Figure 9. Pharmaceutical and Biotechnology Companies
Figure 10. Others
Figure 11. Biotechnology and Pharmaceutical Gases Report Years Considered
Figure 12. Global Biotechnology and Pharmaceutical Gases Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 14. Global Biotechnology and Pharmaceutical Gases Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Biotechnology and Pharmaceutical Gases Revenue Market Share by Region (2020-2031)
Figure 16. Global Biotechnology and Pharmaceutical Gases Sales (2020-2031) & (Kilotons)
Figure 17. Global Biotechnology and Pharmaceutical Gases Sales (CAGR) by Region (2020-2031) (Kilotons)
Figure 18. Global Biotechnology and Pharmaceutical Gases Sales Market Share by Region (2020-2031)
Figure 19. Global Biotechnology and Pharmaceutical Gases Capacity, Production and Utilization (2020-2031) & (Kilotons)
Figure 20. Global Biotechnology and Pharmaceutical Gases Production Trend by Region (2020-2031) (Kilotons)
Figure 21. Global Biotechnology and Pharmaceutical Gases Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Biotechnology and Pharmaceutical Gases Production Growth Rate in North America (2020-2031) & (Kilotons)
Figure 24. Biotechnology and Pharmaceutical Gases Production Growth Rate in Europe (2020-2031) & (Kilotons)
Figure 25. Biotechnology and Pharmaceutical Gases Production Growth Rate in China (2020-2031) & (Kilotons)
Figure 26. Biotechnology and Pharmaceutical Gases Production Growth Rate in Japan (2020-2031) & (Kilotons)
Figure 27. Top 5 and Top 10 Manufacturers Biotechnology and Pharmaceutical Gases Sales Volume Market Share in 2024
Figure 28. Global Biotechnology and Pharmaceutical Gases Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. Carbon Dioxide Revenue Market Share by Manufacturer in 2024
Figure 31. Nitrogen Revenue Market Share by Manufacturer in 2024
Figure 32. Oxygen Revenue Market Share by Manufacturer in 2024
Figure 33. Others Revenue Market Share by Manufacturer in 2024
Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 36. Global Biotechnology and Pharmaceutical Gases Sales Market Share by Type (2020-2031)
Figure 37. Global Biotechnology and Pharmaceutical Gases Revenue Market Share by Type (2020-2031)
Figure 38. Global Biotechnology and Pharmaceutical Gases Sales Market Share by Application (2020-2031)
Figure 39. Global Biotechnology and Pharmaceutical Gases Revenue Market Share by Application (2020-2031)
Figure 40. North America Biotechnology and Pharmaceutical Gases Sales YoY (2020-2031) & (Kilotons)
Figure 41. North America Biotechnology and Pharmaceutical Gases Revenue YoY (2020-2031) & (US$ Million)
Figure 42. North America Top 5 Manufacturers Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) in 2024
Figure 43. North America Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Type (2020- 2031)
Figure 44. North America Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 45. North America Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Application (2020-2031)
Figure 46. North America Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. US Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 48. Canada Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 49. Mexico Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 50. Europe Biotechnology and Pharmaceutical Gases Sales YoY (2020-2031) & (Kilotons)
Figure 51. Europe Biotechnology and Pharmaceutical Gases Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Europe Top 5 Manufacturers Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) in 2024
Figure 53. Europe Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Type (2020-2031)
Figure 54. Europe Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Type (2020-2031)
Figure 55. Europe Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Application (2020-2031)
Figure 56. Europe Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Germany Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 58. France Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 59. U.K. Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 60. Italy Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 61. Russia Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales YoY (2020-2031) & (Kilotons)
Figure 63. Asia-Pacific Biotechnology and Pharmaceutical Gases Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Top 8 Manufacturers Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) in 2024
Figure 65. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Type (2020- 2031)
Figure 66. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 67. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Application (2020-2031)
Figure 68. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Indonesia Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 70. Japan Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 71. South Korea Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 72. China Taiwan Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 73. India Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
Figure 74. Central and South America Biotechnology and Pharmaceutical Gases Sales YoY (2020-2031) & (Kilotons)
Figure 75. Central and South America Biotechnology and Pharmaceutical Gases Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Central and South America Top 5 Manufacturers Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) in 2024
Figure 77. Central and South America Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Type (2021-2031)
Figure 78. Central and South America Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Central and South America Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Application (2020-2031)
Figure 80. Central and South America Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. Brazil Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
Figure 82. Argentina Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
Figure 83. Middle East, and Africa Biotechnology and Pharmaceutical Gases Sales YoY (2020-2031) & (Kilotons)
Figure 84. Middle East and Africa Biotechnology and Pharmaceutical Gases Revenue YoY (2020-2031) & (US$ Million)
Figure 85. Middle East and Africa Top 5 Manufacturers Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) in 2024
Figure 86. Middle East and Africa Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Type (2021-2031)
Figure 87. South America Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Type (2020-2031)
Figure 88. Middle East and Africa Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Application (2020-2031)
Figure 89. Middle East and Africa Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Application (2020-2031)
Figure 90. GCC Countries Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
Figure 91. Turkey Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
Figure 92. Egypt Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
Figure 93. South Africa Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
Figure 94. Biotechnology and Pharmaceutical Gases Industry Chain Mapping
Figure 95. Regional Biotechnology and Pharmaceutical Gases Manufacturing Base Distribution (%)
Figure 96. Biotechnology and Pharmaceutical Gases Production Process
Figure 97. Regional Biotechnology and Pharmaceutical Gases Production Cost Structure
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed